Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Its structure supports the development of novel isoquinoline-based therapeutics with potential anticonvulsant and neuroprotective properties. Also employed in the design of kinase inhibitors for oncology applications due to its ability to bind specific enzyme active sites. Commonly utilized in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates.